Company / Depreciation & Amortization
enGene Holdings Inc. Depreciation & Amortization History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$500.0K
FY2025
5-year range
$200.0K / $500.0K
FY2022-FY2025
Trend
+66.7%
vs FY2024
Sector context
#155 of 192
Health Care
What the data says
enGene Holdings Inc.'s depreciation & amortization of $500,000 is lower than 81% of companies in the Health Care sector (FY2025). Increased from $200,000 to $500,000 over the past 2 years.
Based on SEC 10-K filings.
$500,000 in FY2025 with a 3-year CAGR of +35.7%.
Increased from $200,000 to $500,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +35.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 192This company $500.0K Sector average $188.2M
▼
-99.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +35.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 66.7% year-over-year.
- Ranks #155 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $500.0K | +66.7% |
| FY2024 | $300.0K | +50.0% |
| FY2023 | $200.0K | +0.0% |
| FY2022 | $200.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026